Pericardial Effusion in Obstructive Sleep Apnea without Pulmonary Arterial Hypertension and Daily Hypoxemia - is it Unusual?

Year 2018, Volume: 35 Issue: 3, 233 - 237, 01.05.2018

Emil İvanov Manov Ventsislava Pencheva Nikolay Margaritov Runev Stefan Naydenov Daniela Stoychkova Petrova Ognian Borisov Georgiev

Abstract

Background: Pericardial effusion in chronic hypoxemic lung diseases, such as Obstructive Sleep Apnea syndrome, usually occurs after the development of severe pulmonary arterial hypertension. However, data about the frequency of pericardial effusions in Obstructive Sleep Apnea syndrome without pulmonary arterial hypertension and/or daytime hypoxemia are still scarce, and their pathogenesis is unclear.Aims: To assess the prevalence of pericardial effusions and their volume and location in patients with obesity and Obstructive Sleep Apnea syndrome without pulmonary arterial hypertension and/or hypoxemia.Study Design: Cross-sectional study. Methods: We included 279 consecutive patients (162 males) with newly diagnosed Obstructive Sleep Apnea syndrome having a mean age of 42.8±12.4 years and a mean body mass index of 37.3±7.8 kg/m2. Obstructive Sleep Apnea syndrome was confirmed by polysomnography. Main exclusion criteria were concomitant inflammatory diseases, thyroid dysfunction, daytime hypoxemia, nephrotic syndrome, left ventricular systolic dysfunction and pulmonary arterial hypertension.Results: Pericardial effusion was found in 102 (36.56%) -all of them with moderate to severe obstructive Sleep Apnea syndrome. The mean effusion volume was mild to moderate (up to 250 mL). In 36 patients (35.3%) the pericardial effusion was diffuse, in 42 (41.2%), the pericardial effusion was located in front of the right atrium and the right ventricle, and in 24 (23.5%) the pericardial effusion was situated in front of the right cardiac cavities and the left atrium. We found a significant positive correlation between the presence of pericardial effusion and apnea-hypopnea index (r=0.374, p<0.001), body mass index (r=0.473, p<0.001), and desaturation time during sleep (r=0.289, p<0.001).Conclusion: Pericardial effusion in patients with obesity and moderate to severe Obstructive Sleep Apnea syndrome without daily hypoxemia and/or pulmonary hypertension is a relatively common finding. The occurrence of pericardial effusions is dependent mostly on the grade of Obstructive Sleep Apnea syndrome, degree of obesity, and duration of sleep desaturation.

Keywords

Obesity, obstructive sleep apnea, pericardial effusion

References

• 1. Guilleminault C, Tilkian A, Dement WC. The sleep apnea syndromes. Annu Rev Med 1976;27:465-84.
• 2. Punjabi NM. The Epidemiology of Adult Obstructive Sleep Apnea. Proc Am Thorac Soc 2008;5:136-43.
• 3. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365:1046- 53.
• 4. Natanzon A, Kronzon I. Pericardial and pleural effusions in congestive heart failure - anatomical, pathophysiologic, and clinical considerations. Am J Med Sci 2009;338:211-6.
• 5. Johnson JL. Pleural effusions in cardiovascular disease. Pearls for correlating the evidence with the cause. Postgrad Med 2000;107:95-101.
• 6. Wiener-Kronish JP, Matthay MA, Callen PW, Filly RA, Gamsu G, Staub NC. Relationship of pleural effusions to pulmonary hemodynamics in patients with congestive heart failure. Am Rev Respir Dis 1985;132:1253-6.
• 7. Ohshima S, Gotoh K, Yagi Y, Yamamoto N, Iida M, Deguchi F, et al. Role of systemic and pulmonary hemodynamics in genesis pleural effusion in congestive heart failure. Kokyu To Junkan 1990;38:1133-8.
• 8. Luo YF, Robbins IM, Karatas M, Brixey AG, Rice TW, Light RW. Frequency of pleural effusions in patients with pulmonary arterial hypertension associated with connective tissue diseases. Chest 2011;140:42-7.
• 9. Al-Dhahir HAA, Baay AS, Abbas AH. Pericardial Effusion in Chronic Hypoxic Lung Diseases. Medical Journal of Babylon 2013;10:1.
• 10. Raymond RJ, Hinderliter AL, Willis PW, Ralph D, Caldwell EJ, Williams W, et al. Echocardiographic Predictors of Adverse Outcomes in Primary Pulmonary Hypertension. J Am Coll Cardiol 2002;39:1214-9.
• 11. Brixey AG, Light RW. Pleural effusions occurring with right heart failure. Curr Opin Pulm Med 2011;17:226-31.
• 12. Epstein LJ, Kristo D, Strollo PJ Jr, Friedman N, Malhotra A, Patil SP, et al. Clinical Guideline for the Evaluation Management and Long-term Care of Obstructive Sleep Apnea in Adults. J Clin Sleep Med 2009;5:263-76.
• 13. Akinci SB, Gaine SP, Post W, Merrit WT, Tan HP, Winters B. Cardiac tamponade in an orthotopic liver recipient with pulmonary hypertension. Crit Care Med 2002;30:699-701.
• 14. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, et al. Obesity and Cardiovascular Disease Pathophysiology, Evaluation, and Effect of Weight Loss. Arterioscler Thromb Vasc Biol 2006;26:968-76.
• 15. Manna P, Jain SK. Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies. Metab Syndr Relat Disord 2015;13:423-44.
• 16. Ansari A, Rholl AO. Pseudopericardial effusion: echocardiographic and computed tomographic correlations. Clin Cardiol 1986;9:551-5.
• 17. Fernández-Sánchez A, Madrigal-Santillán E, Bautista M, Esquivel-Soto J, MoralesGonzález A, Esquivel-Chirino C, et al. Inflammation, oxidative stress, and obesity. Int J Mol Sci 2011;12:3117-32.
• 18. Savini I, Catani MV, Evangelista D, Gasperi V, Avigliano L. Obesity-associated oxidative stress: strategies finalized to improve redox state. Int J Mol Sci 2013;14:10497-538.